Resumen
Healthcare-associated pneumonia (HCAP) is a unique entity that differs from community-acquired pneumonia in both bacteriology and outcomes and has similarities to hospital-acquired pneumonia and ventilator-associated pneumonia. HCAP patients are at higher risk of potential multidrug-resistant pathogens, including resistant gram-negative organisms, especially Pseudomonas aeruginosa and Acinetobacter spp., but also extended-spectrum β-lactamases (ESBLs). This manuscript reviews the epidemiology, etiology, and clinical outcomes of hospitalized HCAP patients due to gram-negative bacteria. We will focus our attention on the potential multidrug-resistant pathogens to suggest a new treatment approach for these patients.
Idioma original | English (US) |
---|---|
Páginas (desde-hasta) | 61-66 |
Número de páginas | 6 |
Publicación | Seminars in Respiratory and Critical Care Medicine |
Volumen | 30 |
N.º | 1 |
DOI | |
Estado | Published - feb 2009 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine